title: Neostigmine product for NMBA reversal approved by FDA.
authors.forename: Cheryl A
authors.initials: CA
authors.lastname: Thompson
mesh_terms: D017277:Drug Approval; D006801:Humans; D009388:Neostigmine / Q000008:administration & dosage*; D019148:Neuromuscular Blockade / Q000009:adverse effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D010277:Parasympathomimetics / Q000008:administration & dosage; D014481:United States
chemical_list: D003473:Neuromuscular Nondepolarizing Agents; D010277:Parasympathomimetics; D009388:Neostigmine